These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 3232125

  • 1. Importance of a 3-O-sulfate group in a heparin pentasaccharide for antithrombotic activity.
    Walenga JM, Petitou M, Samama M, Fareed J, Choay J.
    Thromb Res; 1988 Dec 15; 52(6):553-63. PubMed ID: 3232125
    [Abstract] [Full Text] [Related]

  • 2. Antithrombotic activity of a synthetic heparin pentasaccharide in a rabbit stasis thrombosis model using different thrombogenic challenges.
    Walenga JM, Petitou M, Lormeau JC, Samama M, Fareed J, Choay J.
    Thromb Res; 1987 Apr 15; 46(2):187-98. PubMed ID: 3603420
    [Abstract] [Full Text] [Related]

  • 3. Antifactor Xa activity and antithrombotic activity in rats of structural analogues of the minimum antithrombin III binding sequence: discovery of compounds with a longer duration of action than of the natural pentasaccharide.
    Meuleman DG, Hobbelen PM, Van Dinther TG, Vogel GM, Van Boeckel CA, Moelker HC.
    Semin Thromb Hemost; 1991 Apr 15; 17 Suppl 1():112-7. PubMed ID: 2068564
    [Abstract] [Full Text] [Related]

  • 4. Biologic studies on chemically synthesized pentasaccharide and tetrasaccharide fragments.
    Choay J.
    Semin Thromb Hemost; 1985 Apr 15; 11(2):81-5. PubMed ID: 4035368
    [Abstract] [Full Text] [Related]

  • 5. The inhibition of the generation of thrombin and the antithrombotic effect of a pentasaccharide with sole anti-factor Xa activity.
    Walenga JM, Bara L, Petitou M, Samama M, Fareed J, Choay J.
    Thromb Res; 1988 Jul 01; 51(1):23-33. PubMed ID: 3166242
    [Abstract] [Full Text] [Related]

  • 6. Biochemical and pharmacological properties of SANORG 34006, a potent and long-acting synthetic pentasaccharide.
    Herbert JM, Hérault JP, Bernat A, van Amsterdam RG, Lormeau JC, Petitou M, van Boeckel C, Hoffmann P, Meuleman DG.
    Blood; 1998 Jun 01; 91(11):4197-205. PubMed ID: 9596667
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of new synthetic heparin mimetics on whole blood thrombin generation in vivo and in vitro in rats.
    Hérault JP, Bernat A, Gaich C, Herbert M.
    Thromb Haemost; 2002 Feb 01; 87(2):238-44. PubMed ID: 11858483
    [Abstract] [Full Text] [Related]

  • 12. Pentasaccharide and Orgaran arrest, whereas heparin delays thrombus formation in a rat arteriovenous shunt.
    Vogel GM, van Amsterdam RG, Kop WJ, Meuleman DG.
    Thromb Haemost; 1993 Jan 11; 69(1):29-34. PubMed ID: 8446935
    [Abstract] [Full Text] [Related]

  • 13. Preliminary biochemical and pharmacologic studies on a chemically synthesized pentasaccharide.
    Walenga JM, Fareed J.
    Semin Thromb Hemost; 1985 Apr 11; 11(2):89-99. PubMed ID: 4035370
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Antithrombotic effects of heparin oligosaccharides.
    Mattsson C, Palm M, Söderberg K, Holmer E.
    Ann N Y Acad Sci; 1989 Apr 11; 556():323-32. PubMed ID: 2735663
    [Abstract] [Full Text] [Related]

  • 19. From heparin to EP217609: the long way to a new pentasaccharide-based neutralisable anticoagulant with an unprecedented pharmacological profile.
    Petitou M, Nancy-Portebois V, Dubreucq G, Motte V, Meuleman D, de Kort M, van Boeckel CA, Vogel GM, Wisse JA.
    Thromb Haemost; 2009 Nov 11; 102(5):804-10. PubMed ID: 19888512
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of pentasaccharide in a dog model of hemodialysis.
    Hoppensteadt DA, Jeske WP, Walenga JM, Fu K, Yang LH, Ing T, Herbert JM, Fareed J.
    Thromb Res; 1997 Oct 15; 88(2):159-70. PubMed ID: 9361369
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.